All Blogs

Jan 16, 2025

Breakthrough Therapies Shaping the Future of Acute Kidney Injury Treatment



Jan 15, 2025

The Evolution and Impact of Electronic Health Records (EHRs) in Modern Healthcare


Jan 14, 2025

Agios’ PYRUKYND SNDA Accepted by FDA for Thalassemia; BridgeBio’s BBO-8520 Gets FDA Fast Track for KRASG12C-Mutated Lung Cancer; Nipocalimab Granted FDA Priority Review for Myasthenia Gravis; Rigel’s R289 Receives FDA Orphan Drug Designation for MDS; Rise Therapeutics Gets FDA IND Clearance for R-5780 in Cancer


Jan 13, 2025

Bristol Mayer Squibb — The Undisputed Leader in the Molecular Glue Arena


Jan 09, 2025

Roche Secures FDA Clearance for High-Volume Slide Scanner; Pacira Gets 510(k) Approval for Iovera° SmartTip for Chronic Back Pain; ClearCut Presents Clearcoast™ Study Results at San Antonio Breast Cancer Symposium; NanoVibronix Completes UroShield® Pilot Study at University of Michigan; Hologic Finalizes Acquisition of Gynesonics; Movano Health Launches EvieAI Virtual Wellness Assistant.


Jan 07, 2025

Chimerix Submits Dordaviprone NDA for Accelerated Approval in Recurrent H3 K27M-Mutant Diffuse Glioma to FDA; NMD Pharma’s NMD670 Receives FDA Orphan Drug Designation for Charcot-Marie-Tooth Disease; Verastem’s Avutometinib NDA Accepted for KRAS Mutant Ovarian Cancer; Capricor Submits BLA for Deramiocel in Duchenne Muscular Dystrophy; Axsome Completes Phase III Trial of AXS-05 for Alzheimer’s Agitation


Jan 08, 2025

The Promise of Big Data in Healthcare: Transforming Treatment and Outcomes


Jan 10, 2025

The Rise of Molecular Glues: Transforming Protein-Protein Interactions into Therapeutic Opportunities


Jan 06, 2025

Lilly’s ZEPBOUND Clears Hurdle in Sleep Apnea Treatment